https://european-biotechnology.net/wp-content/uploads/2026/03/amol-tyagi-zyJyB9S1oZs-unsplash-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-03-04 08:45:512026-03-04 08:45:51Boehringer steps back from MASH programm as OSE restructure its pipeline
https://european-biotechnology.net/wp-content/uploads/2026/03/nvision-PHIP-Nagel-Luca-TUM.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-03-03 07:34:012026-03-03 07:34:01NVision visualizes metabolics at work and expands to the Cambridge Innovation Cluster
https://european-biotechnology.net/wp-content/uploads/2026/02/Sitryx-Lab-1_web960540.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-27 10:45:162026-02-27 10:45:16Sitryx adds another BigPharma and partners with Boehringer Ingelheim in autoimmune push
https://european-biotechnology.net/wp-content/uploads/2026/02/2018_09_20_novonordisk.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-26 09:29:032026-02-26 09:29:03Novo Nordisk partners with MIT spinout Vivtex in deal worth up to $2.1bn to advance oral biologics for obesity
https://european-biotechnology.net/wp-content/uploads/2026/02/beiersdorf-creme-cosmetics-skin-care_56125-original.jpg541960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-24 19:22:052026-02-24 19:22:05Skin in the AI game: Beiersdorf Ventures invests in AI biology platform Turbine
https://european-biotechnology.net/wp-content/uploads/2026/02/2df70ab08d11aba18b7034ad3ee221fe7d614101-1030x686-1.jpg6861030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-02-24 11:49:292026-02-24 11:49:29Brainomix extends Series C to £18.8m as Oxford AI imaging spinout pushes into the US
